• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular basis of the severe ectopic browning transition of adipocytes in novel mice with resistance against obesity and diabetes

Research Project

Project/Area Number 26461369
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Metabolomics
Research InstitutionToho University

Principal Investigator

JIANG Meizi  東邦大学, 医学部, 非常勤研究生 (00624066)

Co-Investigator(Renkei-kenkyūsha) BUJO Hideaki  東邦大学, 医学部, 教授 (80291300)
Research Collaborator SHIMIZU Naomi  東邦大学, 医学部, 講師 (30375802)
HIGASHI Morihiko  埼玉医科大学, 医学部, 准教授 (00323395)
Antonio Vidal-Puig  University of Cambridge, Addenbrooke's Hospital Metabolic Research Laboratories, 教授
Project Period (FY) 2014-04-01 – 2017-03-31
Project Status Completed (Fiscal Year 2016)
Budget Amount *help
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
KeywordsLR11 / エネルギー消費 / 褐色細胞 / 機能獲得 / 肥満 / 糖尿病 / 熱代謝 / 褐色分化 / インスリン抵抗性 / ノックアウトマウス / 褐色脂肪 / 可溶性LR11 / 皮下脂肪
Outline of Final Research Achievements

This study was aimed to clarify the mechanism underlying the regulation for the functional transition from white adipocytes to brown adipocytes, and to propose a novel modulation therapy for diabetes and obesity. Cell biological analyses showed that LR11 played an important role as an inhibitor in the functional acquisition of brown adipocytes. Intracellular signal analyses showed that, in the inhibition activity of soluble LR11 for the browning differentiation, LR11 was thought to at least in part inhibit the BMP7-induced signal cascade by the complex formation with the receptor BMPR. Taken together, LR11 was an inhibitor for the functional acquisition of brown adipocytes, and is possibly applied for the novel therapy for obesity and diabetes.

Report

(4 results)
  • 2016 Annual Research Report   Final Research Report ( PDF )
  • 2015 Research-status Report
  • 2014 Research-status Report
  • Research Products

    (7 results)

All 2016 2015 2014

All Journal Article (6 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 6 results,  Open Access: 6 results,  Acknowledgement Compliant: 5 results) Presentation (1 results) (of which Int'l Joint Research: 1 results)

  • [Journal Article] Soluble LR11 is a novel biomarker for vascular lesions late after Kawasaki disease.2015

    • Author(s)
      Watanabe K, Suzuki H, Jiang M, Haniu H, Numano F, Hoshina S, Saitoh A, Uchiyama M, Bujo H.
    • Journal Title

      Atherosclerosis

      Volume: 246 Pages: 94-97

    • Related Report
      2015 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Prognostic impact of circulating soluble LR11 on long-term clinical outcomes in patients with coronary artery disease.2015

    • Author(s)
      Ogita M, Miyauchi K, Kasai T, Tsuboi S, Wada H, Naito R, Konishi H2, Dohi T2, Tamura H2, Okazaki S2, Yanagisawa N, Shimada K, Suwa S, Jiang M, Bujo H, Daida H
    • Journal Title

      Atherosclerosis

      Volume: 244 Pages: 216-221

    • Related Report
      2015 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Unsuppressed lipolysis in adipocytes is linked with enhanced gluconeogenesis and altered bile acid physiology in Insr(P1195L/+) mice fed high-fat-diet.2015

    • Author(s)
      Lee EY, Sakurai K, Zhang X, Toda C, Tanaka T, Jiang M, Shirasawa T, Tachibana K, Yokote K, Vidal-Puig A, Minokoshi Y, Miki T.
    • Journal Title

      Sci Rep

      Volume: 30 Issue: 1 Pages: 17565-17565

    • DOI

      10.1038/srep17565

    • Related Report
      2015 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
  • [Journal Article] Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans.2015

    • Author(s)
      Whittle AJ, Jiang M, Peirce V, Relat J, Virtue S, Ebinuma H, Fukamachi I, Yamaguchi T, Takahashi M, Murano T, Tatsuno I, Takeuchi M, Nakaseko C, Jin W, Jin Z, Campbell M, Schneider WJ, Vidal-Puig A, Bujo H.
    • Journal Title

      Nat Commun

      Volume: 6 Issue: 1 Pages: 8951-8951

    • DOI

      10.1038/ncomms9951

    • Related Report
      2015 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Circulating soluble LR11, a novel marker of smooth muscle cell proliferation, is enhanced after coronary stenting in response to vascular injury.2014

    • Author(s)
      Ogita M, Miyauchi K, Jiang M, Kasai T, Tsuboi S, Naito R, Konishi H1, Dohi T1, Yokoyama T, Okazaki S, Shimada K, Bujo H, Daida H
    • Journal Title

      Atherosclerosis.

      Volume: 237 Pages: 374-378

    • Related Report
      2014 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytes.2014

    • Author(s)
      Tsukamoto S, Takeuchi M, Kawaguchi T, Togasaki E, Yamazaki A, Sugita Y, Muto T, Sakai S, Takeda Y, Ohwada C, Sakaida E, Shimizu N, Nishii K, Jiang M, Yokote K, Bujo H, Nakaseko C.
    • Journal Title

      Exp Mol Med.

      Volume: - Issue: 4 Pages: 46-89

    • DOI

      10.1038/emm.2013.161

    • Related Report
      2014 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] Identification of a regulator for energy expenditure in adipose tissues2016

    • Author(s)
      姜 美子、武城 英明
    • Organizer
      18th International Conference on Emerging Infectious Diseases (EID)
    • Place of Presentation
      ワシントンD.C.(アメリカ)
    • Year and Date
      2016-01-13
    • Related Report
      2015 Research-status Report
    • Int'l Joint Research

URL: 

Published: 2014-04-04   Modified: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi